Your session is about to expire
← Back to Search
At-Home tDCS for Depression in Pregnancy
Study Summary
This trial will compare transcranial direct current stimulation (tDCS) against a sham condition to see if it is more effective at reducing symptoms of depression in pregnant people with moderate to severe depression. 156 participants will be enrolled at various data collection points throughout pregnancy and up to one year postpartum.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently experiencing a moderate to severe depressive episode without psychosis.I do not use benzodiazepines or anticonvulsants regularly, except for low-dose lorazepam.I have visible skin issues or rashes where electrodes might be placed on my scalp.I am pregnant with one baby and between 12 to 32 weeks along.I do not have any severe or life-threatening illnesses, including advanced cancer, severe pregnancy complications, or neurological conditions.I am 18 years old or older.I haven't started any new depression treatments in the last 4 weeks.
- Group 1: active tDCS
- Group 2: control
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this research still possible?
"According to the official data published on clinicaltrials.gov, this research project is still open for participants and was first announced on November 8th 2021 with an update being made as recently as February 3rd 2022."
What is the current intake capacity of this experiment?
"Affirmative. Clinicaltrials.gov's data confirms that, as of February 3rd 2022, this medical experiment is actively seeking patients to complete their trial. The initial posting was on November 8th 2021 and the team needs 156 participants across two different sites in order to complete the study successfully."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger